Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December
November 04 2019 - 7:30AM
Business Wire
Apyx Medical Corporation, formerly Bovie Medical
Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical
devices and supplies and the developer of its Helium Plasma
Technology, marketed and sold as Renuvion® in the cosmetic surgery
market and as J-Plasma® in the hospital surgical market, announced
today that management will participate in the following upcoming
investor conferences:
The 10th Annual Craig-Hallum Alpha Select Conference at
the Sheraton New York Times Square Hotel in New York, New York.
- Management will participate in 1x1 meetings on Tuesday,
November 12. There will be no formal presentation.
The Stifel 2019 Healthcare Conference at the Lotte New
York Palace Hotel in New York, New York.
- Management will present on Wednesday, November 20 at 10:55 a.m.
Eastern Time.
The 31st Annual Piper Jaffray Healthcare
Conference at the Lotte New York Palace in New York, New
York.
- Management will participate in a fireside chat on Wednesday,
December 4 at 4:30 p.m. Eastern Time.
Live audio webcasts of the presentations will be provided under
the ‘Company Events’ section of the Apyx Medical Corporation
investor relations website at
https://apyxmedical.com/investor_relations/. An archive of the
webcast will be available for replay following the conferences.
About Apyx Medical
Corporation:
Apyx Medical Corporation (formerly Bovie Medical Corporation) is
an advanced energy technology company with a passion for elevating
people’s lives through innovative products in the cosmetic and
surgical markets. Known for its innovative Helium Plasma
Technology, Apyx is solely focused on bringing transformative
solutions to the physicians and patients it serves. The company’s
Helium Plasma Technology is marketed and sold as Renuvion® in the
cosmetic surgery market and J-Plasma® in the hospital surgical
market. Renuvion offers plastic surgeons, fascial plastic surgeons
and cosmetic physicians a unique ability to provide controlled heat
to the tissue to achieve their desired results. The J-Plasma system
allows surgeons to operate with a high level of precision and
virtually eliminating unintended tissue trauma. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through original equipment manufacturing (OEM) agreements
with other medical device manufacturers. For further information
about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191104005199/en/
Investor Relations:
Westwicke Partners on behalf of Apyx Medical Corporation Mike
Piccinino, CFA investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Apr 2023 to Apr 2024